CTRI/2023/07/055205尚未招募2 期
Evaluation of In vitro Anti-psoriatic Activity of a Novel Polyherbal UNIMFormulation by Multiparametric Analysis - NI
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with clinically diagnosed Psoriasis and healthy controls with matched temperament.
- •Age: 20-50 years.
- •With any duration of the disease, site, extension and distribution of the lesions.
- •Willingness to give written informed consent form.
排除标准
- •Subjects with Psoriasis treatment with other drug /systems.
- •History of drug or alcoholic abuse, chronic smokers not willing to abstain from smoking during the study period.
- •Any clinically significant abnormality identified on physical examination/laboratory tests.
- •Subjects having any systemic disease and other skin diseases.
- •Subjects with known allergies. Impaired cardiac, hepatic and renal function. History of malignancy. Concomitant use of any other antioxidants.
- •Pregnant and other lactating women. Pregnant and other lactating women.
研究者
相似试验
进行中（未招募）
不适用
Determination of antipsoriatic efficacy of topical paroxetine hydrochloride ointments in a psoriasis plaque testhealthy subjectsEUCTR2004-004740-51-DEAgis Industries (1983) ltd.15
进行中（未招募）
不适用
Determination of antipsoriatic efficacy of topical formulations and comparison to a brand medication and placebo in a psoriasis plaque testMale or female subjects aged 18 to 64 are eligible for the study insofar that they suffer from chronic plaque type psoriasis.EUCTR2005-004859-35-DEG&W Laboratories, Inc.15
进行中（未招募）
不适用
Determination of antipsoriatic efficacy of topical formulations in a psoriasis plaque test - Psoriasis plaque testmale or female subjects with chronic plaque type psoriasisEUCTR2006-001186-42-DEAstion Danmark A/S15
进行中（未招募）
不适用
A phase II trial to evaluate the anti-psoriatic efficacy and tolerability of tazarotene in a gel formulation in patients with mild to moderate nail psoriasis - parallel group comparisoEUCTR2013-004519-28-DEAlmirall Hermal GmbH
尚未招募
2 期
Epidermal Growth Factor adjuvant therapy for psoriasisPsoriasis.PsoriasisIRCT20141007019432N8Tehran University of Medical Sciences21